MGNX

1.9650.76%
MC

Meenu Chhabra Karson

Independent Director

Ms. Meenu Chhabra Karson, M.B.A., B.Sc., serves as Director of Vasomune Inc. She is Independent Director of MacroGenics, Inc. since January 3, 2023. She has been the Chief Executive Officer and President at Proteostasis Therapeutics, Inc. since May, 2014. She has been a biotech CEO at Proteostasis Therapeutics. She also serves as non-executive chairperson for Harness Therapeutics. She was Executive Chair of Samsara Therapeutics Inc. until 2025. Her initial focus is driving the development of Proteostasis' cystic fibrosis franchise while leveraging its platform to identify pipeline appropriate assets addressing orphan and neurodegenerative disease indications. She has extensive managerial experience in the biopharmaceutical industry with a strong track record of corporate execution. Prior to joining Proteostasis, she served as the Chief Executive Officer and President of Allozyne Inc. from August 2007 to May 2014. While at Allozyne, she implemented a strategy to maximize the value of the proprietary platform by building a portfolio of risk reward balanced product candidates including antibody drug conjugates. She served as the Chief Business Officer of BioXell S.p.A. from July 2003 to November 2006. She served as Vice President, Business Development and Licensing for Novartis Consumer Health (Geneva, Switzerland) and Novartis AG from December 2006 to August 2007. She joined BioXell in September 2003 as Director of Business Development and Commercial Strategy. Prior to BioXell, she held various sales, marketing and business development positions in major pharmaceutical companies (most notably, Bristol Myers Squibb Inc., Parke Davis/Warner Lambert and Fresenius Kabi AG). Previously, she served as Business Development Manager at MCR Research Inc. Prior to joining MCR, she served as a Business Development Manager at Fresenius Kabi Healthcare. She has been a Director of Allozyne, Inc. since October 2007 and Proteostasis Therapeutics, Inc. since May, 2014. She holds a Bachelor of Science degree from University of Toronto in Pharmacology and Master's in Business Administration from York University with a focus in Strategy and Finance.

Positions